Publication Name	World Journal of Gastroenterology
Manuscript ID	3595
Country	Australia

Received	2013-05-08 09:16
Peer-Review Started	2013-05-08 11:47
To Make the First Decision	2013-05-14 18:50
Return for Revision	2013-05-20 10:32
Revised	2013-07-13 06:15
Second Decision	2013-08-19 12:25
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-08-20 00:10
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-09-24 11:09
Publish the Manuscript Online	2013-10-18 17:02

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Autobiography
Article Title	Inflammatory bowel disease serology in Asia and the West
Manuscript Source	Invited Manuscript
All Author List	Lani Prideaux, Michael A Kamm, Peter De Cruz, Daniel R van Langenberg, Siew C Ng and Iris Dotan
Funding Agency and Grant Number	Funding Agency Grant Number Broad Foundation (MAK)
Corresponding Author	Michael A Kamm, MD, PhD, FRACP, Professor, Department of Gastroenterology, St Vincent's Hospital, Victoria Parade, Fitzroy 3065, Melbourne, Australia. mkamm@unimelb.edu.au
Key Words	Crohn's disease; Ulcerative colitis; Serological antibodies; Asia; Ethnic; Anti-Saccharomyces cervisiae antibodies; Anti-chitobioside antibodies; Anti-laminaribioside antibodies; Anti-mannobioside antibodies; Atypical perinuclear anti-neutrophil cytoplasmic antibodies
Core Tip	Serological antibodies to enteric antigens are a hallmark of inflammatory bowel disease (IBD) and may carry pathogenic and prognostic significance. There is limited information about their role and prevalence in Asian patients. We evaluated anti-glycan antibodies (anti-chitobioside, anti-laminaribioside, and anti-mannobioside), anti-Saccharomyces cervisiae; and atypical perinuclear anti-neutrophil cytoplasmic antibody in IBD patients, their unaffected relatives, and healthy controls in Australia and Hong Kong (China). Serologic responses were found to differ between Asian and Caucasian patients. Different genetic, environmental or disease pathogenic factors may account for these differences.
Publish Date	2013-10-18 17:02
Citation	Prideaux L, Kamm MA, De Cruz P, van Langenberg DR, Ng SC, Dotan I. Inflammatory bowel disease serology in Asia and the West. World J Gastroenterol 2013; 19(37): 6207-6213
URL	http://www.wjgnet.com/1007-9327/full/v19/i37/6207.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i37.6207

Full Article (PDF)	WJG-19-6207.pdf
Manuscript File	3595-Review.docx
Answering Reviewers	3595-Answering reviewers.pdf
Copyright License Agreement	3595-Copyright assignment.pdf
Peer-review Report	3595-Peer reviewer(s).pdf
Scientific Editor Work List	3595-Scientific editor work list.doc